Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory Pathway
Open Access
- 1 May 2007
- Vol. 26 (5), 593-604
- https://doi.org/10.1016/j.immuni.2007.03.017
Abstract
No abstract availableKeywords
Funding Information
- National Multiple Sclerosis Society
- Taiho Pharmaceutical
- National Institutes of Health (AI 37562)
This publication has 42 references indexed in Scilit:
- The immunoregulatory effects of Qa‐1Immunological Reviews, 2006
- Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanismJournal of Hepatology, 2005
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptorNature, 2005
- IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.Blood, 2005
- Anti-CD3 antibodies: towards clinical antigen-specific immunomodulationCurrent Opinion in Pharmacology, 2004
- Elimination In Vivo of Developing T Cells by Natural Killer CellsThe Journal of Experimental Medicine, 2003
- Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic NeuritisThe Journal of Experimental Medicine, 2003
- Reciprocal Activating Interaction between Natural Killer Cells and Dendritic CellsThe Journal of Experimental Medicine, 2002
- A low polymorphic mouse H-2 class I gene from the Tla complex is expressed in a broad variety of cell types.The Journal of Experimental Medicine, 1987
- Low doses of interferon alpha result in more effective clinical natural killer cell activation.Journal of Clinical Investigation, 1985